Zhongchao (NASDAQ:ZCMD) Stock Gets Downgrade from Wall Street Zen

Zhongchao (NASDAQ:ZCMD) was downgraded by analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Sunday, Wall Street Zen reports.

Separately, Weiss Ratings cut Zhongchao from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Friday, September 25th. One investment analyst has rated the stock with a Sell rating. According to MarketBeat, Zhongchao presently has an average rating of “Sell”.

Zhongchao Stock Performance

ZCMD stock opened at $1.39 on Friday. Zhongchao has a 1-year low of $1.35 and a 1-year high of $1,443.36. The business has a fifty day moving average price of $1.82 and a 200-day moving average price of $108.21.

Zhongchao Company Profile

Zhongchao Inc (NASDAQ:ZCMD) is a China-based healthcare technology company that provides online healthcare information and education services. Its platform is designed to connect medical professionals with educational content, industry information and other digital resources.

The company focuses on supporting healthcare professionals through continuing medical education and related online programs, with an emphasis on improving access to medical knowledge and professional development. Zhongchao also provides health-related information and services intended to support patients and broader healthcare communication.

Zhongchao primarily serves healthcare professionals, patients and other participants in China’s healthcare sector through its digital platforms.